Bank of New York Mellon’s Bio-Path Holdings Inc BPTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-27
Closed -$21K 4325
2018
Q1
$21K Sell
27
-4
-13% -$3.12K ﹤0.01% 4267
2017
Q4
$25K Buy
31
+9
+41% +$11.6K ﹤0.01% 4289
2017
Q3
$31K Hold
22
﹤0.01% 4174
2017
Q2
$34K Sell
22
-56
-72% -$117K ﹤0.01% 4181
2017
Q1
$257K Buy
78
+1
+1% +$3.63K ﹤0.01% 3800
2016
Q4
$414K Buy
77
+2
+3% +$9.69K ﹤0.01% 3666
2016
Q3
$420K Buy
75
+4
+6% +$25.7K ﹤0.01% 3618
2016
Q2
$565K Buy
71
+45
+173% +$456K ﹤0.01% 3467
2016
Q1
$266K Hold
26
﹤0.01% 3684
2015
Q4
$128K Hold
26
﹤0.01% 3999
2015
Q3
$117K Hold
26
﹤0.01% 4067
2015
Q2
$118K Sell
26
-52
-67% -$284K ﹤0.01% 4010
2015
Q1
$564K Hold
78
﹤0.01% 3559
2014
Q4
$833K Sell
78
-1
-1% -$10.3K ﹤0.01% 3406
2014
Q3
$637K Hold
79
﹤0.01% 3535
2014
Q2
$968K Buy
79
+74
+1,480% +$811K ﹤0.01% 3331
2014
Q1
$53K Buy
+5
New +$62.5K ﹤0.01% 4070

Other funds holding BPTH

Bank of New York Mellon's BPTH Position: Q2 2018 in Review

Bank of New York Mellon sold out of Bio-Path Holdings Inc (BPTH) in Q2 2018, closing a stake of 27 shares — an estimated $21K sold.

Bank of New York Mellon first reported a position in BPTH in Q1 2014 and held it in 17 quarters. The position peaked at $968K in Q2 2014. 21 funds tracked by Wall St. Rank hold BPTH as of Q2 2018.

  • Bank of New York Mellon reported no remaining Bio-Path Holdings Inc position as of Q2 2018 after selling out during the quarter.
  • Bank of New York Mellon sold 27 Bio-Path Holdings Inc shares in Q2 2018, an estimated $21K.
  • Bank of New York Mellon first reported a position in Bio-Path Holdings Inc in Q1 2014 and held it in 17 quarters.
  • Bank of New York Mellon's Bio-Path Holdings Inc position peaked at $968K in Q2 2014.
  • 21 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2018.

Based on Bank of New York Mellon's 13F filing for Q2 2018, filed 6 Aug 2018.